495 related articles for article (PubMed ID: 32413933)
1. Adalimumab for maintenance of remission in Crohn's disease.
Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
[TBL] [Abstract][Full Text] [Related]
3. Budesonide for induction of remission in Crohn's disease.
Rezaie A; Kuenzig ME; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH; Kaplan GG; Seow CH
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD000296. PubMed ID: 26039678
[TBL] [Abstract][Full Text] [Related]
4. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000543. PubMed ID: 32786164
[TBL] [Abstract][Full Text] [Related]
5. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Wang Y; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
[TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
7. Infliximab for maintenance of medically-induced remission in Crohn's disease.
Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
[TBL] [Abstract][Full Text] [Related]
8. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
Garg SK; Croft AM; Bager P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
[TBL] [Abstract][Full Text] [Related]
9. Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Patton PH; Parker CE; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD000299. PubMed ID: 27444319
[TBL] [Abstract][Full Text] [Related]
10. Interventions for fatigue in inflammatory bowel disease.
Farrell D; Artom M; Czuber-Dochan W; Jelsness-Jørgensen LP; Norton C; Savage E
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012005. PubMed ID: 32297974
[TBL] [Abstract][Full Text] [Related]
11. Stem cell transplantation for induction of remission in medically refractory Crohn's disease.
El-Nakeep S; Shawky A; Abbas SF; Abdel Latif O
Cochrane Database Syst Rev; 2022 May; 5(5):CD013070. PubMed ID: 35556242
[TBL] [Abstract][Full Text] [Related]
12. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Pandit NG; Zaman M; Minkoff NZ; Tanner-Smith EE; Gomez-Duarte OG; Acra S; Nicholson MR
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD012774. PubMed ID: 37094824
[TBL] [Abstract][Full Text] [Related]
13. Infliximab for medical induction of remission in Crohn's disease.
Gordon M; Sinopoulou V; Akobeng AK; Radford SJ; Eldragini MEAA; Darie AM; Moran GW
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012623. PubMed ID: 37982428
[TBL] [Abstract][Full Text] [Related]
14. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
Gordon M; Sinopoulou V; Iheozor-Ejiofor Z; Iqbal T; Allen P; Hoque S; Engineer J; Akobeng AK
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013529. PubMed ID: 33471939
[TBL] [Abstract][Full Text] [Related]
15. Interventions for treating lymphocytic colitis.
Chande N; Al Yatama N; Bhanji T; Nguyen TM; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006096. PubMed ID: 28702956
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatments for eczema: a network meta-analysis.
Sawangjit R; Dilokthornsakul P; Lloyd-Lavery A; Lai NM; Dellavalle R; Chaiyakunapruk N
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013206. PubMed ID: 32927498
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D for the treatment of inflammatory bowel disease.
Wallace C; Gordon M; Sinopoulou V; Limketkai BN
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD011806. PubMed ID: 37781953
[TBL] [Abstract][Full Text] [Related]
18. Vedolizumab for induction and maintenance of remission in Crohn's disease.
Hui S; Sinopoulou V; Gordon M; Aali G; Krishna A; Ding NS; Boyapati RK
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013611. PubMed ID: 37458279
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of eosinophilic esophagitis.
Franciosi JP; Gordon M; Sinopoulou V; Dellon ES; Gupta SK; Reed CC; Gutiérrez-Junquera C; Venkatesh RD; Erwin EA; Egiz A; Elleithy A; Mougey EB
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD004065. PubMed ID: 37470293
[TBL] [Abstract][Full Text] [Related]
20. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.
Law CC; Bell C; Koh D; Bao Y; Jairath V; Narula N
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013256. PubMed ID: 33098570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
